- •Protocolized team-based care lowered SOFA scores at the time of MCS and Exit therapy (transplant/LVAD) in cardiogenic shock
- •Lower SOFA score at the time of ‘Exit’ therapy was associated with improved 6-month survival in patients with cardiogenic shock due to end-stage heart failure.
- •SOFA score 9 or more at the time of Exit therapy was associated with poor 6-month survival
- •SOFA score may be used to guide the timing of transplantation/LVAD implant in patients with end-stage HF on temporary MCS
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Clinical practice patterns in temporary mechanical circulatory support for shock in the critical care cardiology trials network (CCCTN) registry.Circ. Heart Fail. 2019; 12e006635
- Cardiogenic shock teams and centres: a contemporary review of multidisciplinary care for cardiogenic shock.ESC Heart Fail. 2021; 8: 988-998
- The SOFA score-development, utility and challenges of accurate assessment in clinical trials.Crit. Care. 2019; 23: 374
- Mechanical circulatory support for decompensated heart failure.Curr. Heart Fail. Rep. 2017; 14: 365-375
- Standardized team-based care for cardiogenic shock.J. Am. Coll. Cardiol. 2019; 73: 1659-1669
- Clinical outcomes associated with acute mechanical circulatory support ytilization in heart failure related cardiogenic shock.Circ. Heart Fail. 2021; 15e007924
- Early escalation of mechanical circulatory support stabilzes and potentially rescues patients in refractory cardiogenic shock.Circ. Heart Fail. 2020; 13e005853
- Relation of the sequential organ failure assessment score to morbidity and mortality after cardiac surgery.Ann. Thorac. Surg. 2006; 82: 2072-2078
- Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: use of the model of end-stage liver disease (MELD) and MELD excluding INR (MELD-XI) scoring system.J. Heart Lung Transplant. 2012; 31: 601-610